2 Assessing symptoms of interstitial lung disease and COVID-19

2 Assessing symptoms of interstitial lung disease and COVID-19

2.1 Be aware that patients taking drugs that affect the immune response may have atypical presentations of COVID‑19. For example, patients taking corticosteroids may not develop a fever.

2.2 Be aware that some adverse effects caused by antifibrotic drugs and immunosuppressants may be mistaken for symptoms of COVID‑19, for example diarrhoea, fatigue and loss of appetite.

2.3 Be aware that symptoms of COVID‑19 can be similar to the symptoms of the patient's underlying condition.

2.4 Be aware that both interstitial lung disease and COVID‑19 are associated with an increased risk of coagulopathy. Refer to local trust policies if available or see the British Thoracic Society's guidance on venous thromboembolic disease in patients with COVID-19.